Defibrotide for the Treatment of Severe COVID-19
Clinical trial NCT04652115 · RECRUITING
Trial details
- NCT number
- NCT04652115
- Sponsor
- Brigham and Women's Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2026-12-24
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.